
We share your passion for science. Promega is committed to excellence in technologies to assess key processes in targeted protein degradation: compound binding and permeability, ternary complex formation, ubiquitination, and trafficking to proteasome. Assay live cells in kinetic mode to determine target protein degradation rates, DC50 potency values, and recovery profiles. Let’s collaborate.
Team Members

Danette Daniels
R&D Group Leader, Functional Proteomics

Kara Machleidt
Global Commercialization Marketing Manager

Richard Somberg
Director, Pharma/Biotech
